InClin, Inc. - San Mateo, California

Address: 155 Bovet Rd # 660, San Mateo, CA 94402, United States.
Phone: 6503764000.
Website: inclin.com
Specialties: Pharmaceutical company.
Other points of interest: Wheelchair-accessible car park, Wheelchair-accessible entrance.
Opinions: This company has 0 reviews on Google My Business.
Average opinion: 0/5.

📌 Location of InClin, Inc.

InClin, Inc.: A Pharmaceutical Company Overview

For individuals seeking information regarding pharmaceutical ventures, InClin, Inc. presents a noteworthy entity. Located at 155 Bovet Rd # 660, San Mateo, CA 94402, United States, and reachable at Phone: 6503764000, InClin operates as a dedicated pharmaceutical company. Their website, Website: inclin.com, serves as a central hub for detailed information about their operations and offerings. Currently, InClin maintains 0 reviews on Google My Business, resulting in an Average opinion: 0/5, reflecting a nascent presence in publicly available feedback.

Company Background and Specialties

InClin, Inc. specializes in the research, development, and potential commercialization of pharmaceutical products. While specific details about their current product pipeline are not widely publicized, the company’s core competency lies within the pharmaceutical industry. They likely engage in various stages of drug development, from initial discovery and preclinical testing to clinical trials and, potentially, manufacturing and distribution. The company’s focus suggests a commitment to improving patient outcomes through the advancement of novel therapies. Further investigation into their patent filings and research publications would be required to fully delineate their specific therapeutic areas of interest. However, given the competitive nature of the pharmaceutical sector, InClin likely concentrates its efforts on areas with unmet medical needs or opportunities for significant innovation.

Location and Accessibility

The company’s physical location in San Mateo, California, positions it within a thriving biotechnology and pharmaceutical hub. This strategic location offers access to a skilled workforce, established research institutions, and a supportive ecosystem for pharmaceutical innovation. Furthermore, InClin demonstrates a commitment to inclusivity by providing wheelchair-accessible car park and a wheelchair-accessible entrance, ensuring accessibility for all visitors and employees. This consideration highlights a dedication to providing a welcoming and accommodating environment. The address facilitates easy navigation and provides a tangible point of contact for inquiries.

Key Features and Information

Here's a summary of key information regarding InClin, Inc.:

  • Company Type: Pharmaceutical Company
  • Address: 155 Bovet Rd # 660, San Mateo, CA 94402, United States
  • Phone: 6503764000
  • Website: inclin.com
  • Specialties: Pharmaceutical Research & Development
  • Accessibility: Wheelchair Accessible

It's important to note that due to the limited publicly available information, a comprehensive understanding of InClin’s specific activities and future plans remains challenging. However, their presence within the San Mateo biotechnology corridor and their designation as a pharmaceutical company suggest a credible and potentially impactful participant in the industry.

Recommendations for Prospective Researchers

For individuals interested in learning more about InClin, Inc., several avenues can be explored:

  • Visit the Website: inclin.com offers the most direct access to company information, including potential product pipelines, research publications, and contact details.
  • Contact the Company Directly: Utilizing the provided phone number, 6503764000, allows for direct communication with InClin representatives to inquire about specific areas of interest.
  • Patent Database Searches: Examining patent databases (e.g., Google Patents, USPTO) can reveal details about InClin’s research and development activities.
  • Industry News and Publications: Monitoring pharmaceutical industry news sources and publications may provide updates regarding InClin’s progress and announcements.

Despite the lack of recent reviews, InClin’s established location and designation as a pharmaceutical entity warrant continued interest and investigation. Further research is encouraged to gain a deeper understanding of their contributions to the field.

Go up